The CFO of OptimizeRx Corporation is Exercising Options


Today it was reported that the CFO of OptimizeRx Corporation (OPRX), Douglas Baker, exercised options to buy 8,334 OPRX shares at $3.15 a share, for a total transaction value of $26.25K. The options were close to expired and Douglas Baker retained stocks.

Following this transaction Douglas Baker’s holding in the company was increased by 15.56% to a total of $839.8K. Following Douglas Baker’s last OPRX Buy transaction on May 03, 2019, the stock climbed by 2.9%.

See today’s analyst top recommended stocks >>

Based on OptimizeRx Corporation’s latest earnings report for the quarter ending December 31, the company posted quarterly revenue of $6.58 million and GAAP net loss of $109.9K. In comparison, last year the company earned revenue of $4.11 million and had a GAAP net loss of $189.2K. Currently, OptimizeRx Corporation has an average volume of 110.1K. The Company has a Price to Book ratio of 8.8504.

Starting in June 2018, OPRX received 15 Buy ratings in a row.

The insider sentiment on OptimizeRx Corporation has been neutral according to 32 insider trades in the past three months. This sentiment is slightly higher than the average sentiment of company insiders in this sector.

Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

OptimizeRx Corp. engages in the provision of digital health messaging via electronic health records, which serves as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers EHR workflow solutions which include financial messaging, patient education, and brand messaging; and brand support.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts